AARD · Aardvark Therapeutics, Inc.
$6.82
+0.93 (+15.79%)
At close · Aug 21
Market Cap
$149.25M
Shares
21.88M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Nelson Sun | Chief Operating Officer | Appointed | 2026-02-12 |
Key facts
CIK
1774857
CUSIP
002942100
13F (30d)
63 filings
63 filers
Visit website
Investor relations